Related Experiment Video
Updated: Mar 15, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity,
Nikhilesh Bhatt1, Mintu Turakhia2, Thomas J Fogarty3
1Fogarty Institute for Innovation.
Insights
Atrial fibrillation (AF) treatments like catheter ablation have high recurrence rates and modest benefits. Cardiac radiosurgery (CRS) offers a potentially more effective and cost-efficient non-invasive alternative for AF patients.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Health Economics
Background:
- Atrial fibrillation (AF) is a prevalent cardiovascular condition in the U.S., leading to increased hospitalizations and significant healthcare costs.
- Current AF treatments, such as catheter ablation, demonstrate limited efficacy, high recurrence rates, and questionable cost-effectiveness compared to conventional therapies.
- A substantial unmet need exists for more consistent, effective, and cost-efficient AF treatment options.
Purpose of the Study:
- To analyze current healthcare utilization and expenditures for AF treatment.
- To evaluate the cost-effectiveness of catheter ablation for AF.
- To project the potential cost-effectiveness of cardiac radiosurgery (CRS) as a novel non-invasive AF therapy.
Main Methods:
- Review of current healthcare utilization and expenditures in AF treatment.
- Cost-effectiveness analysis of catheter ablation for AF.
- Modeling and projection of the cost-effectiveness of cardiac radiosurgery (CRS) for AF treatment.
Main Results:
- Catheter ablation for AF provides modest improvements in quality-adjusted life years and has not demonstrated clear cost-utility advantages.
- The recurrence rate for AF following catheter ablation is notably high, indicating limitations in current therapeutic approaches.
- Cardiac radiosurgery (CRS) presents a potential for remarkable cost-effectiveness and robust patient outcomes in AF treatment.
Conclusions:
- There is a significant clinical need for improved AF therapies beyond current standards like catheter ablation.
- Cardiac radiosurgery (CRS), a non-invasive ablation technique, shows promise for higher efficacy and more consistent results in treating AF.
- Further investigation into CRS is warranted to establish its cost-effectiveness and clinical utility for managing atrial fibrillation.
Abstract:
In the United States (U.S.), atrial fibrillation (AF) is the second-most common cardiovascular condition after hypertension, affecting four million Americans each year. Individuals with AF are three times more likely to be hospitalized over the span of a year when compared to medically matched control groups. The considerably large clinical population of individuals with AF mandates that the cost-effectiveness and efficacy of current treatment regimens for AF have egregious implications for health care spending and public health. Unfortunately, catheter ablation for AF treatment has been shown to make only modest gains in quality-adjusted life years, has yet to demonstrate cost-utility advantages over conventional therapies for AF, and has a reported rate of recurrence for AF that is notably high. Thus, there is a major unmet clinical need for a therapeutic option to treat AF that produces more consistent and efficacious results that are cost-effective. Cardiac radiosurgery as a therapy for AF has the potential to be remarkably cost-effective and produce robust patient outcomes. CyberHeart Inc. has developed the world's first-ever cardiac radiosurgery (CRS) system designed to ablate the heart non-invasively. Procedures that ablate the heart utilizing the Cyberheart CRS system are anticipated to allow higher efficacy and more consistent results than current techniques such as catheter ablation. The aim of this study is to present the current healthcare utilization and expenditures in AF treatment, report the cost-effectiveness of catheter ablation for AF, and project the potential cost-effectiveness of cardiac radiosurgery for the treatment of AF.
